| Primary |
| Myasthenia Gravis |
66.7% |
| Myasthenic Syndrome |
5.1% |
| Ocular Myasthenia |
5.1% |
| Anaesthesia |
3.8% |
| Muscular Weakness |
3.8% |
| Myasthenia Gravis Crisis |
3.8% |
| Product Used For Unknown Indication |
3.8% |
| Blood Pressure Management |
1.3% |
| Drug Therapy |
1.3% |
| Drug Use For Unknown Indication |
1.3% |
| Hypertension |
1.3% |
| Parkinson's Disease |
1.3% |
| Systemic Lupus Erythematosus |
1.3% |
|
| Pharmaceutical Product Complaint |
25.0% |
| Product Quality Issue |
14.6% |
| Drug Ineffective |
8.3% |
| Palpitations |
6.3% |
| Grand Mal Convulsion |
4.2% |
| Muscular Weakness |
4.2% |
| Poor Quality Drug Administered |
4.2% |
| Suicide Attempt |
4.2% |
| Therapeutic Response Unexpected With Drug Substitution |
4.2% |
| Viith Nerve Paralysis |
4.2% |
| Asthenia |
2.1% |
| Caesarean Section |
2.1% |
| Circumstance Or Information Capable Of Leading To Medication Error |
2.1% |
| Condition Aggravated |
2.1% |
| Diarrhoea |
2.1% |
| Drug Intolerance |
2.1% |
| Dyskinesia |
2.1% |
| Dyspnoea |
2.1% |
| Epilepsy |
2.1% |
| Eye Disorder |
2.1% |
|
| Secondary |
| Myasthenia Gravis |
46.8% |
| Product Used For Unknown Indication |
6.4% |
| Immunosuppressant Drug Therapy |
5.3% |
| Mycobacterial Infection |
4.3% |
| Rheumatoid Arthritis |
4.3% |
| Breast Cancer Stage I |
3.2% |
| Breast Cancer Stage Ii |
3.2% |
| Dyslipidaemia |
3.2% |
| Evidence Based Treatment |
3.2% |
| Ocular Myasthenia |
3.2% |
| Anaesthesia |
2.1% |
| Antiviral Treatment |
2.1% |
| Crohn's Disease |
2.1% |
| Eyelid Ptosis |
2.1% |
| Maintenance Of Anaesthesia |
2.1% |
| Type 2 Diabetes Mellitus |
2.1% |
| Acute Disseminated Encephalomyelitis |
1.1% |
| Cholelithiasis |
1.1% |
| Drug Use For Unknown Indication |
1.1% |
| Hormone Therapy |
1.1% |
|
| Hypertransaminasaemia |
10.7% |
| Toxic Epidermal Necrolysis |
10.7% |
| Grand Mal Convulsion |
7.1% |
| Melanocytic Naevus |
7.1% |
| Oesophageal Perforation |
7.1% |
| White Blood Cell Count Decreased |
7.1% |
| Acute Febrile Neutrophilic Dermatosis |
3.6% |
| Cardiac Arrest |
3.6% |
| Circumstance Or Information Capable Of Leading To Medication Error |
3.6% |
| Dyskinesia |
3.6% |
| Epilepsy |
3.6% |
| Large Intestine Perforation |
3.6% |
| Meningitis Cryptococcal |
3.6% |
| Myasthenia Gravis Crisis |
3.6% |
| Mycobacterial Infection |
3.6% |
| Nausea |
3.6% |
| Pancreatic Mass |
3.6% |
| Pneumonia |
3.6% |
| Pneumonitis |
3.6% |
| Progressive Multifocal Leukoencephalopathy |
3.6% |
|
| Concomitant |
| Drug Use For Unknown Indication |
16.1% |
| Myasthenia Gravis |
15.0% |
| Surgery |
14.7% |
| Product Used For Unknown Indication |
9.6% |
| Prophylaxis |
6.3% |
| Hypertension |
6.0% |
| Medical Diet |
4.6% |
| Abdominal Pain |
4.4% |
| Oesophagitis |
3.8% |
| Hiv Infection |
2.4% |
| Osteoporosis |
2.4% |
| Gastritis |
2.0% |
| Pain |
2.0% |
| Epilepsy |
1.8% |
| Liver Carcinoma Ruptured |
1.7% |
| Hepatic Neoplasm Malignant |
1.5% |
| Hypoalbuminaemia |
1.5% |
| Nuclear Magnetic Resonance Imaging |
1.5% |
| Muscular Weakness |
1.4% |
| Diabetes Mellitus |
1.2% |
|
| Myasthenia Gravis |
21.1% |
| Fatigue |
8.4% |
| Pyrexia |
5.3% |
| Suicidal Ideation |
5.3% |
| Thrombocytopenia |
5.3% |
| Urticaria |
5.3% |
| Abdominal Pain |
4.2% |
| Grand Mal Convulsion |
4.2% |
| Pancreatitis |
4.2% |
| Pruritus |
4.2% |
| Tachycardia |
4.2% |
| Chorea |
3.2% |
| Cough |
3.2% |
| Myalgia |
3.2% |
| Pain |
3.2% |
| Pneumonia |
3.2% |
| Sepsis |
3.2% |
| Tachypnoea |
3.2% |
| Throat Tightness |
3.2% |
| Tremor |
3.2% |
|
